Prospective comparative study of characteristics associated with influenza A and B in adults;Étude prospective comparative des caractéristiques cliniques et biologiques des grippes A et B chez l'adulte

Medecine et Maladies Infectieuses

Volumn 48, Issue 3, 2018, Pages 180-187

  Chagvardieff, A ^a   Persico, N ^a   Marmillot, C ^a   Badiaga, S ^a,b   Charrel, R ^c   Roch, A ^a,b,c,d  

^a HÔPITAL NORD   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c Aix Marseille University IRD 190 Inserm 1207   (France)

^d AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Epidemiology; Influenza; Pneumonia; Rapid diagnostic test

Indexed keywords

ANTIVIRUS AGENT; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT; VIRUS ANTIGEN; VIRUS RNA;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; EMERGENCY WARD; EPIDEMIC; EPIDEMIOLOGICAL DATA; FEMALE; FLU LIKE SYNDROME; HUMAN; INFLUENZA A; INFLUENZA B; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SENSITIVITY ANALYSIS; SEX RATIO; VACCINATION; VIRUS PNEUMONIA; VIRUS STRAIN; BLOOD; BREATHING RATE; COMORBIDITY; EARLY DIAGNOSIS; GENETICS; HOSPITAL EMERGENCY SERVICE; IMMUNOASSAY; INFLUENZA; INFLUENZA A VIRUS; INFLUENZA B VIRUS; ISOLATION AND PURIFICATION; MIDDLE AGED; PROCEDURES; SYMPTOM ASSESSMENT; VIROLOGY;

ADULT; AGED; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; COMORBIDITY; DISEASE OUTBREAKS; EARLY DIAGNOSIS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; IMMUNOASSAY; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PNEUMONIA, VIRAL; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RESPIRATORY RATE; RISK FACTORS; RNA, VIRAL; SYMPTOM ASSESSMENT;

EID: 85037996004     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2017.11.007     Document Type: Article

References (38)

1. World Health Organization Influenza. Fact sheet no. 211. 2016. [Cited 2005 Apr 25].
2. Girard, M.P., Tam, J.S., Assossou, O.M., et al. The 2009 A (H1N1) influenza virus pandemic: a review. Vaccine 28:31 (2010), 4895–4902.
3. Reed, C., Chaves, S.S., Perez, A., et al. Complications among adults hospitalized with influenza: a comparison of seasonal influenza and the 2009 H1N1 pandemic. Clin Infect Dis 59:2 (2014), 166–174.
4. Glezen, W.P., Schmier, J.K., Kuehn, C.M., et al. The burden of influenza B: a structured literature review. Am J Public Health 103:3 (2013), e43–e51.
5. Gutierrez-Pizarraya, A., Perez-Romero, P., Alvarez, R., et al. Unexpected severity of cases of influenza B infection in patients that required hospitalization during the first postpandemic wave. J Infect 65 (2012), 423–430.
6. Taubenberger, J.K., Morens, D.M., The pathology of influenza virus infections. Annu Rev Pathol 3 (2008), 499–522.
7. Wie, S.H., So, B.H., Song, J.Y., et al. A comparison of the clinical and epidemiological characteristics of adult patients with laboratory-confirmed influenza A or B during the 2011–2012 influenza season in Korea: a multi-center study. PLoSOne, 8(5), 2013, e62685.
8. Mosnier, A., Caini, S., Daviaud, I., et al. GROG network. Clinical characteristics are similar across type A and B influenza virus infections. PLoS One, 10(9), 2015, e0136186.
9. Cohen, J.M., Silva, M.L., Caini, S., et al. IBGP study team. Striking similarities in the presentation and duration of illness of influenza A and B in the community: a study based on sentinel surveillance networks in france and turkey, 2010–2012. PLoS One, 10(10), 2015, e0139431.
10. Belchior, E., Surveillance épidémiologique et virologique de la grippe en France métropolitaine, saison 2013–2014. Bull Epidemiol Hebd 28 (2014), 460–465.
11. Smith, A.B., Mock, V., Melear, R., Colarusso, P., Willis, D.E., Rapid detection of influenza A and B viruses in clinical specimens by Light Cycler real time RT-PCR. J Clin Virol 28:1 (2003), 51–58.
12. Yang, X., Yao, Y., Chen, M., Yang, X., Xie, Y., et al. Etiology and clinical characteristics of influenza-like illness (ILI) in outpatients in Beijing. June 2010 to May 2011. PLoS One, 7, 2012, e28786.
13. Woolpert, T., Brodine, S., Lemus, H., Waalen, J., Blair, P., et al. Determination of clinical and demographic predictors of laboratory-confirmed influenza with subtype analysis. BMC Infect Dis, 12, 2012, 129.
14. Dai, X.Q., Liu, M., Zhang, T.H., Yang, X.S., Li, S.L., et al. Clinical predictors for diagnosing pandemic (H1N1) 2009 and seasonal influenza (H3N2) in fever clinics in Beijing. China. Biomed Environ Sci 25 (2012), 61–68.
15. Douwe, F., Postma and CAP-START Study Group. Antibiotic treatment strategies for community-acquired pneumonia in adults. N Engl J Med 372 (2015), 1312–1323.
16. SPILF, Prise en charge des infections des voies respiratoires basses de l'adulte immunocompétent; conférence de consensus. 2006.
17. Glezen, W.P., Changing epidemiology of influenza B virus. Clin Infect Dis, 2014, ciu668.
18. Équipes de surveillance de la grippe, Surveillance épidémiologique et virologique de la grippe en France, saison 2012–2013. Bull Epidemiol Hebd(32), 2013, 394–401.
19. Irving, S.A., Patel, D.C., Kieke, B.A., Donahue, J.G., Vandermause, M.F., Shay, D.K., et al. Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004–2005 through 2007–2008. Influenza Other Respir Viruses 6:1 (2012), 37–43.
20. Hinds, A.M., Bozat-Emre, S., Van Caeseele, P., Mahmud, S.M., Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada. BMC Public Health, 15(1), 2015, 35.
21. Xu, C., Iuliano, A.D., Chen, M., et al. Characteristics of hospitalized cases with influenza A (H1N1) pdm09 infection during first winter season of post-pandemic in China. PloS one, 8(2), 2013, e55016.
22. Su, S., Chaves, S.S., Perez, A., D'Mello, T., Kirley, P.D., Yousey-Hindes, K., et al. Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection. Clin Infect Dis 59:2 (2014), 252–255.
23. Kawai, N., Ikematsu, H., Iwaki, N., Kawashima, T., Maeda, T., Mitsuoka, S., et al. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir. J Infect 55:3 (2007), 267–272.
24. Kawai, N., Ikematsu, H., Iwaki, N., Maeda, T., Satoh, I., Hirotsu, N., et al. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003–2004 and 2004–2005 influenza seasons. Clin Infect Dis 43:4 (2006), 439–444.
25. Hurt, A.C., McKimm-Breschkin, J.L., McDonald, M., Barr, I.G., Komadina, N., Hampson, A.W., Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs. Virus Res 103:1–2 (2004), 205–211.
26. Farrukee, R., Mosse, J., Hurt, A.C., Review of the clinical effectiveness of the neuraminidase inhibitors against influenza B viruses. Expert Rev Anti Infect Ther 11:11 (2013), 1135–1145.
27. Cheng, A.C., Holmes, M., Dwyer, D.E., Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2015: the influenza complications alert network. Commun Dis Intell Q Rep 40:4 (2016), E521–E526.
28. Paddock, C.D., Liu, L., Denison, A.M., et al. Myocardial injury and bacterial pneumonia clinical microbiology and infection contribute to the pathogenesis of fatal influenza B virus infection. J Infect Dis 205 (2012), 895–905.
29. Myles, P.R., Semple, M.G., Lim, W.S., et al. Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009–2010 in the UK. Thorax 67 (2012), 709–717.
30. Dunning, A., DiazGranados, C., Voloshen, T., et al. Correlates of protection against influenza in the elderly: results from an influenza vaccine efficacy trial. Clin Vaccine Immunol 23:3 (2016), 228–235.
31. DiazGranados, C.A., Dunning, A.J., Kimmel, M., et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 371:7 (2014), 635–645, 10.1056/NEJMoa1315727.
32. Shaw, M.W., Xu, X., Li, Y., Normand, S., Ueki, R.T., Kunimoto, G.Y., et al. Reapparence and global spread of variants of influenza B/Victoria lineage viruses in the 2000–2001 and 2001–2002 seasons. Virology, 2002.
33. Falsey, A.R., Murata, Y., Walsh, E.E., Impact of rapid diagnosis on management of adults hospitalized with influenza. Arch Intern Med, 167, 2007, 354e60.
34. González-Del Vecchio, M., Catalán, P., de Gea, V., Rodríguez-Borlado, A., Martos, C., Padilla, B., et al. An algorithm to diagnose influenza infection: evaluating the clinical importance and impact on hospital costs of screening with rapid antigen detection tests. Eur J Clin Microbiol Infect Dis 34:6 (2015), 1081–1085.
35. Chartrand, C., Leeflang, M.M.G., Minion, J., Brewer, T., Pai, M., Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med 156:7 (2012), 500–511.
36. Cho, C.H., Woo, M.K., Kim, J.Y., Cheong, S., Lee, C.-K., An, S.A., et al. Evaluation of five rapid diagnostic kits for; influenza A/B virus. J Virol Methods 187:1 (2013), 51–56.
37. Ruest, A., Michaud, S., Deslandes, S., Frost, E.H., Comparison of the Directigen flu A + B test, the QuickVue influenza test, and clinical case definition to viral culture and reverse transcription-PCR for rapid diagnosis of influenza virus infection. J Clin Microbiol 41:8 (2003), 3487–3493.
38. ® Flu/RSV XC assay for rapid detection of influenza A, influenza B, and respiratory syncytial virus. Diagn Microbiol Infect Dis 81:4 (2015), 256–258.